AI assistant
Vericel Corp — Board/Management Information 2014
May 12, 2014
31799_rns_2014-05-12_dc87c7d7-9891-48f6-87b5-5527f63344bf.zip
Board/Management Information
Open in viewerOpens in your device viewer
8-K 1 a14-12481_28k.htm 8-K
*UNITED STATES SECURITIES AND EXCHANGE COMMISSION*
*WASHINGTON, D.C. 20549*
*FORM 8-K*
*CURRENT REPORT*
*Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934*
Date of Report (Date of Earliest Event Reported): May 12, 2014 (May 7, 2014)
*Aastrom Biosciences, Inc.*
(Exact name of registrant as specified in its charter)
| Michigan | 000-22025 | 94-3096597 |
|---|---|---|
| (State or other jurisdiction | (Commission | (I.R.S. Employer |
| of incorporation) | File Number) | Identification No.) |
| 24 Frank Lloyd Wright Drive, Lobby K, Ann Arbor, Michigan | 48105 |
|---|---|
| (Address of principal executive offices) | (Zip Code) |
Registrants telephone number, including area code: (800) 556-0311
*Not Applicable*
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
SEQ.=1,FOLIO='',FILE='C:\JMS\C901710\14-12481-2\task6780015\12481-2-ba.htm',USER='C901710',CD='May 12 21:26 2014'
*Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.*
On May 7, 2014, the Board of Directors of Aastrom Biosciences, Inc., a Michigan corporation (the Company) appointed Dominick C. Colangelo as the Companys Chief Accounting Officer and Treasurer. Mr. Colangelo will continue to serve as the Companys President and Chief Executive Officer, a position he has held with the Company since March 1, 2013.
2
SEQ.=1,FOLIO='2',FILE='C:\JMS\C901710\14-12481-2\task6780015\12481-2-ba.htm',USER='C901710',CD='May 12 21:26 2014'
*SIGNATURES*
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| /s/ DOMINICK C. COLANGELO |
|---|
| Name: Dominick C. Colangelo |
| Title: Chief Executive Officer and President |
3
SEQ.=1,FOLIO='3',FILE='C:\JMS\C901710\14-12481-2\task6780015\12481-2-ba.htm',USER='C901710',CD='May 12 21:26 2014'